Cipla forms JV with Jiangsu Acebright for respiratory medicines in China
Posted by
www.biotecnika.org
The agreement is between Chinese firm Jiangsu Acebright and Cipla's
European arm, Cipla EU for a combined investment of USD 30 million, as
per a company statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-forms-jv-with-jiangsu-acebright-for-respiratory-medicines-in-china/articleshow/70242041.cms
Subscribe to:
Post Comments (Atom)
Post a Comment